No image published for this recall
Over-the-counter and prescription ranitidine drugs (LATEST UPDATE: March 11, 2022 – Pharmascience Inc. Recall)
Official notice
11 Mar 2022
Last checked
11 Mar 2022
An official Health Canada notice concerns Over-the-counter and prescription ranitidine drugs (LATEST UPDATE: March 11, 2022 – Pharmascience Inc. Recall). Ranitidine products recalled because of a nitrosamine impurity Published 2022-03-11.
What to do now
Talk to your doctor or pharmacist at your earliest convenience about alternative, non-ranitidine treatment options appropriate for your health circumstances. There are many prescription and over-the-counter drug alternatives in Canada that are authorized for the same or similar uses as ranitidine. Individuals taking a prescription ranitidine drug, including a recalled product, should not stop taking it unless they have spoken to their health care provider and obtained alternative treatment, as the risk of not treating the condition may be greater than the risk related to NDMA exposure. Contact your health care provider if you have taken a ranitidine product and you have concerns about your health. Report any health product adverse events or complaints to Health Canada. Canadians with questions about the recalls can contactApotex Inc. Via Stericycle Inc. At 1-877-574-5043;Dominion Pharmacal at 1-888-550-6060, or by e-mail at med. Info@pharmascience. Com. Laboratoire Riva Inc. At 1-450-434-7482, or by e-mail at jlavoie@labriva. Com. Pro Doc Limitée at 1-800-361-8559, or by e-mail at medinfo@prodoc. Qc. Ca. Ranbaxy Pharmaceuticals Canada Inc. At 1-866-840-1340, or by e-mail at canadacustomerservice@sunpharma. ComSandoz Canada at 1-800-361-3062;Sanis Health Inc. At 1-866-236-4076;Sanofi Consumer Health Inc. At 1-800-636-3664 or by email at Ch. Canada-ConsumerCare@sanofi. Com. Sivem Pharmaceuticals ULC at 1-855-757-4836;Pharmascience Inc. At 1-888-550-6060, or by email at med. Info@pharmascience. Com. Teva Canada Limited at 1-800-268-4129;Vita Health Products Inc. At 1-877-637-7557. Related links. Health Canada assessing NDMA in ranitidine (2019-09-13)Apotex Inc. Ranitidine recall (2019-09-24)Sanofi Consumer Health Inc. Zantac recall (2019-10-18)Pharmascience Inc. Ranitidine recall (2019-10-25)Vita Health Products Inc. Ranitidine recall (2019-10-25)Health Canada updates Canadians on its ongoing assessment of nitrosamine impurities in certain drugs (2019-12-02)Status of ranitidine drugs in Canada (2020-07-23)
Recall number
59609
Official notice
2022-03-11
The hazard
The hazard
Ranitidine products recalled because of a nitrosamine impurity
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Follow the official notice if they match.
Recall Numbers
Checked manually this time?
The app alerts you when a new official recall is published — no searching, no checking back.
Turn on recall alertsWhere it was sold
Where it was sold
The source does not list specific retailers. See the official notice for where affected products were sold.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand: Over-the-counter And Prescription Ranitidine Drugs.
Source & status
Source & status
Source
Tier
Category
App estimate
Recall details
Recall details
Recall number
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.
This recall was published 11 Mar 2022. The next one won't wait for you to search.
RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.
